002210 — Dongsung Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesAdventurousMicro Cap

Annual balance sheet for Dongsung Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	R2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	5,143	4,094	6,435	3,145	3,863
Net Total Accounts Receivable
Net Total Receivables	27,903	33,083	31,291	29,100	21,719
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	49,986	54,389	60,815	56,908	88,888
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	37,378	43,960	42,725	73,450	72,041
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	104,582	107,702	114,973	140,668	168,443
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	37,589	47,571	44,844	76,999	129,699
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	58,141	64,893	75,171	96,701	145,072
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Total Equity	46,440	42,809	39,802	43,968	23,371
Total Liabilities & Shareholders' Equity	104,582	107,702	114,973	140,668	168,443
Total Common Shares Outstanding